Loading...
UK Trademark — IPO
SK biopharmaceuticals
Application UK00801413890 · Registered
Quick Facts
| Application Number | UK00801413890 |
| Status | Registered |
| Owner | SK Inc. |
| Filed | 2018-04-05 |
| Registered | 2018-12-21 |
| Renewal Due | 2028-04-05 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Is this trademark active?
Yes. SK biopharmaceuticals is currently a registered UK trademark, with renewal due on 2028-04-05. It is protected under UK intellectual property law and can be enforced against infringing uses.
Mark Details (as filed at the IPO)
Mark description / limitation
Colour Claimed : The mark consists of the letters "SK" in red stylized font and "biopharmaceuticals" in orange stylized font; to the top right of the "SK" is a design of wings; the inner portion of the wings is red, and the outer portion of the wings is orange; white is not claimed as a feature of the mark and only represents background or transparent areas.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 42 — Scientific & IT Services
Conducting technical project studies; research and development of new products for others; testing, inspection, or research of pharmaceuticals, cosmetics or foodstuff; research relating to pharmaceuticals; medical research services; research and development of technology for medicinal chemical manufacturing; research for medical products; providing information on the test, inspection, or research of medical products; research and development in the pharmaceutical and biotechnology fields; pharmaceutical product evaluation; medical product testing; research relating to biotechnology; development of biotechnology; biotechnology services; biochemistry research services; biochemical analysis; development and test of chemical production methods; chemistry services; chemical research.
Device Elements (Vienna Classification)
This figurative mark is indexed under the following Vienna categories by the UK IPO:
- 03.13.01 — Animals
- 25.05.94 — Ornamental motifs, surfaces or backgrounds with ornaments
- 29.01.01 — Colours
Timeline
- Filed: 2018-04-05
- Registered: 2018-12-21
- Renewal due: 2028-04-05
About This Trademark
'SK biopharmaceuticals' is a registered trademark on the UK IPO register, owned by SK Inc.. The application (UK00801413890) was filed on 5 April 2018 and registered on 21 December 2018. The registration is set to expire on 5 April 2028.
This mark is recorded under Class 42 (scientific, IT & design services), specifically covering: Colour Claimed : The mark consists of the letters "SK" in red stylized font and "biopharmaceuticals" in orange stylized font; to the top right of the "SK" is a design of wings; the inner portion of the wings is red, and the outer portion of the wings is orange; white is not claimed as a feature of the mark and only represents background or transparent areas.
The trademark is represented by Wilson Gunn.
Frequently Asked Questions
Who owns UK trademark UK00801413890 ('SK biopharmaceuticals')?
UK trademark UK00801413890 for the mark 'SK biopharmaceuticals' in Class 42 is recorded on the UK IPO register as owned by SK Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00801413890 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00801413890 for the mark 'SK biopharmaceuticals' as registered.
Which goods or services does UK trademark UK00801413890 cover?
UK trademark UK00801413890 for the mark 'SK biopharmaceuticals' is registered in Class 42 (scientific, IT & design services). The filed specification reads: Class 42: Conducting technical project studies; research and development of new products for others; testing, inspection, or research of pharmaceuticals, cosmetics or foodstuff; research relating to pharmaceuticals; medical research services; research and development of technology for medicinal chemical manufacturin…
When was UK trademark UK00801413890 filed?
UK trademark UK00801413890 for the mark 'SK biopharmaceuticals' was filed at the UK IPO on 5 April 2018 and registered on 21 December 2018.
When does UK trademark UK00801413890 need to be renewed?
UK trademark UK00801413890 for the mark 'SK biopharmaceuticals' is currently recorded as valid until 5 April 2028, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00801413890?
Wilson Gunn is listed as the attorney / representative of record for UK trademark UK00801413890 for the mark 'SK biopharmaceuticals' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "SK biopharmaceuticals" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| SK BIOPHARMACEUTICALSSame applicant | 97645080 | 700 | 2022-10-24 |
| SK BIOPHARMACEUTICALSSame applicant | 79236983 | 739 | 2018-04-05 |
| SK BIOPHARMACEUTICALSSame applicant | 86774094 | 710 | 2015-09-30 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.